Skip to main content

Table 2 Univariate and multivariate analyses of different prognostic parameters for overall survival of 214 glioblastoma patients

From: The prognostic role of preoperative serum albumin levels in glioblastoma patients

Variable

Univariate

Multivariate

P

HR

95% CI

P

HR

95% CI

Sex

0.880

1.021

0.778-1.339

0.266

1.176

0.883-1.566

Age

0.059

1.011

1.000-1.022

0.466

1.004

0.993-1.016

Tumor size

0.474

1.002

0.997-1.007

0.381

1.002

0.997-1.008

KPS

<0.001

0.964

0.954-0.974

<0.001

0.974

0.963-0.986

Resection

0.014

0.731

0.568-0.940

0.091

0.800

0.618-1.036

Adjuvant treatment

<0.001

0.577

0.487-0.684

0.001

0.726

0.597-0.884

MGMT promoter

0.162

0.823

0.626-1.081

0.925

1.015

0.749-1.375

IDH1-R132H mutation

0.006

0.450

0.255-0.794

0.018

0.489

0.270-0.885

Serum albumin level

<0.001

0.938

0.912-0.964

0.023

0.966

0.938-0.995

  1. IDH, isocitrate dehydrogenase; KPS: Karnofsky Performance Scores; MGMT: O(6)-methylguanine-DNA-methyltransferase.